Cancer deaths to double by 2030, with developing nations seeing biggest rise, says WHO study; Rational use of medicines questioned

3 June 2010

By 2030, around 13.3 million people will die of cancer a year, almost double the number in 2008, a World Health Organization division has revealed. The research, conducted by the International Agency for Research on Cancer (IARC), also indicated that almost 21.4 million new cases of the disease will be diagnosed annually in 2030.

According to GLOBOCAN, an on-line resoruce of the IARC, an estimated 12.7 million new cancer cases and 7.6 million cancer deaths occurred in 2008. Christopher Wild, IARC Director, stated: "These figures represent the most accurate assessment of the global cancer burden available at present and can be used in the setting of priorities for cancer control in different regions of the world; they form a vital foundation to future responses to the UN resolution on non-communicable diseases."

Less-developed regions face a heavier cancer burden

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical